The Ninth IFIP/IEEE International Symposium on Integrated Network
Management (IM 2005) will be held 16-19 May 2005 in Nice, France. IM 2005
will present the latest technical advances in the area of management,
operations and control of networks, networking services, networked
applications, and distributed systems. Details can be found at
http://www.ieee-im.org/. The symposium includes tutorials on the days
before and after the technical program. You are invited to submit tutorial
proposals with the following information:
* Tutorial Title, Full Name of the Instructor
* Biography of the Instructor (100-200 words)
* Outline and Extended Abstract (500-1000 words)
If the tutorial or its earlier version has been given before, please
indicate the events, dates and contents. Tutorial proposals should be sent
to the Tutorial Chair, Masum Hasan (masum(a)cisco.com).
Submission: 30 September 2004
--Masum
http://www.cs.toronto.edu/~zmhasan/http://wwwin-people.cisco.com/masum/ (Cisco Intranet)
Dear all,
please find enclosed the report of Dipak Khakhar for IFIP GA
concerning the DCSC (Developing Countries Support Committee)
grant situation.
It contains the grants which have been given in 2004 and those
which will be given in 2005.
In 2005, TC6 will receive grants for Middleware 2005
and for MWCN 2005 (in both cases 1.500 EURO).
Furthermore there is a description of a "voucher scheme" which
gives information about how to apply for grants and for which
purpose the grants may be given.
Best regards
Otto
Dear all,
the programme of INTELLCOMM 2004 (Bangkok, Thailand; Nov. 23-26,2004)
is available via:
<http://intellcomm2004.ait.ac.th/>
Nov. 23: tutorials day
Nov. 24-26: conference.
Remember that our TC6 meeting 2004/2 will be held in Bankgok
just before the conference, i.e. on
November 21 + 22, 2004
Best regards
Otto
Dear Colleague,
[Apologies for multiple copies of this announcement]
CALL FOR PARTICIPATION
Sultan Qaboos University
Muscat, Oman
ICCCP''05
Sultan Qaboos University,
Muscat, Oman
14-16 February, 2005
1st CALL FOR PAPERS AND TUTORIALS
http://icccp05.tjer.net
icccp_info(a)tjer.net
Regards
Ahmed Al Naamany
=======================================================
Advances in Cancer Therapies 2004
Oncology Research, Novel Biologics and Pharmacogenomics
=======================================================
15th and 16th September 2004, Workshop 14th September 2004
Hilton Kensington Hotel, London
**FINAL AGENDA BELOW - REQUEST YOUR BROCHURE TODAY**
Visiongain b2b Conferences is pleased to announce that 'Advances in Cancer Therapies 2004 - Oncology Research, Novel Biologics and Pharmacogenomics' will be run in mid September this year. This event will follow up on the success of 'Cancer Drugs 2003'. The agenda is nearing completion, now is your chance to register your interest in speaking, sponsoring or attending this leading event.
THEMES TO BE INCLUDED:
** Identify Key Market Segments and Profit From Emerging Trends in Cancer Therapeutics
** Clinical Trials for Cancer - New Approaches to Clinical Development for Your Company
** Learn From the Best Practice Case Studies such as: Taxotere- Zevalin- MabThera- ABXEGF- Oncophage- Arimidex- Thalidomide
** Examine Areas Shaping the Future of Cancer Therapies: Monoclonal Antibodies, Antisense Drugs,Vaccines and Angiogenesis Inhibitors
** Discover how Alliances will Shape the Future of Cancer Therapy, Highlighting Opportunities
KEY SPEAKERS
** Dr. Bruno Osterwalder, VP, Global Head, Early & Strategic Oncology, Roche
** Dr. Peter Blume-Jensen, Head & Director, Molecular Oncology, Serono
** Dr. Jean-Francois Pouliot, Director of Scientific Research- Onclogy, Schering Plough
** Uday Bose, Taxotere Marketing, Aventis Oncology
** Dr. Iris Kuss, COE Study Management Europe, Schering
** Dr. Glen Clack, Clinical Research Physician, AstraZeneca
** Dr. Dimitris Voliotis, Director, Global Clinical Leader, Oncology, Bayer HealthCare
** Dr. Peter Bohlen, Senior VP, Research, ImClone Systems
** Dr. Raymond Withy, Chief Business Officer, Abgenix
** Dr. Ken Watters, VP, Clinical Development and Regulatory Affairs, Celgene Europe Limited
** Dr. Nick Dean, Vice President Functional Genomics, Isis Pharmaceuticals
** Dr. Renu Gupta, Senior Vice President, Development, Antigenics
WHO SHOULD ATTEND THIS EVENT:
**Vice President, Clinical Oncology
**Director of Oncology Development
**Vice President of Clinical Research
**Program Director, Cancer
**Senior Director, Clinical Research
**Director, Experimental Medicine
**Medical Director
**Executive Director for Development
**Global Head of Oncology
-----------------------------------------------------------------
This event will also feature: Pre-conference Interactive Workshop
-----------------------------------------------------------------
**Strategies for Pricing and Market Access of New Oncology Drugs**
Tuesday 14th September 2004
Led by: Ulf Munack, Director, Simon-Kucher & Partners
This workshop will give you the opportunity to engage in knowledge-sharing with fellow professionals, which can result in brainstorming and creating ideas which you can use back in your own organisation.
You can gain a greater understanding of the pathology of pain, have detailed discussions about pain signalling pathways and ventures for new targets.
---------------------
DELEGATE REGISTRATION
---------------------
Places at this event are limited, please call or email me to secure your place.
- PRICING -
Attend the:
** Conference and pre conf. workshop GBP 1600.00 Plus VAT
** Conference only Fee: GBP 1299.00 Plus VAT
** Pre conference workshop only Fee: GBP 650.00 Plus VAT
- BOOKINGS -
Booking is easy, simply contact Christopher Cullinane on:
Telephone: +44 (0)20 8767 6711
Fax: +44 (0)20 8767 5001
Email: mailto:chris.cullinane@visiongain.com
Terms and conditions apply - see below.
If you have any further questions regarding this event and how you can be involved please do not hesitate to ask.
Kind regards,
Christopher Cullinane
Account Manager
Visiongain B2B Conferences
Telephone: +44 (0)20 8767 6711
Fax: +44 (0)20 8767 5001
Email: mailto:chris.cullinane@visiongain.com
******
AGENDA
******
PRE-CONFERENCE INTERACTIVE WORKSHOP
Strategies for Pricing and Market Access of New Oncology Drugs
Tuesday 14th September 2004
Led by: Ulf Munack, Director, Simon-Kucher & Partners
It is of most use to those who are willing and prepared to engage in meaningful discussions and network with others. This 'facilitated open-space' provides you with ideas and time to explore possible new targets of action and benchmark them against other approaches.
Main topics of discussion:
* P&R environment for cancer products in 2004
* Critical success factors for market access in oncology
* Examples of recent learning from new oncology launches
Schedule: The workshop will run from 10:00 until 14:00 with lunch and refreshments at appropriate intervals
DAY 1
WEDNESDAY 15TH SEPTEMBER
09:00 Registration and coffee
09:30 Opening remarks from the Chair
NOVEL APPROACHES TO TARGET VALIDATION
09:40 Signal Transduction-Based Drug Discovery: Oncogenic Kinase Signalling and Molecularly Targeted Therapeutics
* Major post-translational regulatory mechanisms - Reversible protein and lipid phosphorylation controlling cell function
* Causal involvement in human malignancies and immune disorders - perturbation of the normal regulatory mechanisms controlling kinase and phosphatase activity
* Examples from Serono's kinase drug discovery program
* What are the major future challenges for kinase inhibitors as therapeutics? - How to overcome them
Dr. Peter Blume-Jensen
Head & Director, Molecular Oncology
Serono
CLINICAL TRIALS IN CANCER
10:20 New Approaches to Clinical Development: Assess What Will Suit your Needs
* Maximum tolerated dose and biological effective dose: advice on maximising their use
* How to get accurate dose: response information
* How significant is shrinkage / no shrinkage to your clinical development? - Assess and implement
* Reliability of tumour markers - how far should you depend on them? - Practical advice
* Assessment of combination therapy of new drugs with traditional ones - will it work for your drugs?
Dr. MariaGrazia Porro
Associate Director- Clinical Research / Oncology
Nerviano Medical Science
11:00 Morning Coffee
11:20 Design, Interpretation and Outcomes of Phase IIa/IIb Trials in Oncology - The Clinical Perspective
* How to cope with the transition from phase I to II
* Objectives, endpoints, design and patient population
* What's different with targeted/ cytostatic vs cytotoxic compounds?
* Analysis of results and transition into phase III
Dr. Dimitris Voliotis
Director, Global Clinical Leader, Oncology
Bayer HealthCare
COMMERCIAL DEVELOPMENT: CASE STUDIES
12:00 CASE STUDY: Arimidex, A Novel Adjuvant Treatment for Early Breast Cancer in Postmenopausal Women
* Current market for aromatase inhibitors
* First and only AI to be approved in EBC: impact of efficacy and safety analysis in market capture
* Post marketing results: Belgium, Mexico and Japan
* New Results: increased DFS in early adjuvant and switching strategies. What is the real impact in recurrence?
Dr. Glen Clack
Clinical Research Physician
AstraZeneca
12:40 Lunch
14:00 CASE STUDY: Taxotere, How it has Become the World's Largest Selling Breast Cancer Treatment
* Competitors in the field and how to keep the edge
* Market capture in other indications - non small cell lung cancer, gastric, ovarian and neck cancer
* FDA approved new indication - prostate cancer: the future for Taxotere?
* Methods used to establish Taxotere with clinicians - how to optimise market penetration
Uday Bose
Taxotere Marketing
Aventis Oncology
14:40 The Dawn of a New Era in Cancer Therapy
* What did we learn from the evolution of cancer therapy with some practical examples
* The emergence of targeted therapies: what determines their success?
* Where are we going and what will be the impact of the human genome project?
Dr. Jean-Francois Pouliot
Director of Scientific Research
Schering-Plough
15:20 Afternoon Tea
PATENT PROTECTION
15:40 The Shifting Landscape of Patent Protection - Does it Have an Effect on Cancer Diagnostics and Therapies?
* The swinging pendulum of patent protection in the US
* Requirements for patent protection: are cancer diagnostics and therapies any different than for other diagnostics or therapies?
* Do your patents provide sufficient descriptive material to support the full scope of expected protection?
* Do your patent claims really say what you think they do?
* Will you be able to obtain protection for more than a specifically claimed diagnostic / therapy or do you have protection against other diagnostics / therapies that may be "equivalent" to yours
Lawrence Bugaisky
Director
Sterne, Kessler, Goldstein and Fox, PLLC
MONOCLONAL ANTIBODY THERAPIES
16:20 CASE STUDY: ABX-EGF, the Monoclonal Antibody Generated by XenoMouse Technology
* Phase II clinical results: kidney, non-small cell lung, colorectal and prostate cancers
* XenoMouse technology- how can you use it to generate antibodies
* Key product characteristics: using differences between ABX-EGF and drugs targeting the EGF receptor and pathway
Dr. Raymond Withy
President & CEO
Abgenix
17:00 Questions and Discussion
17:20 Close of Day One
DAY TWO
THURSDAY 16TH SEPTEMBER
09:00 Registration and Coffee
09:30 Opening remarks from the Chair
09:40 CASE STUDY: MabThera, the Primary Drug for Treatment of Non-Hodgkin Lymphoma
* Therapeutic work of MabThera - binding to CD20 antigen
* Breakdown of success in event - free survival in patients with aggressive non-Hodgkin lymphona
* New Indications: Rituxan for non-malignant autoimmune disorders?
* Results of ongoing trials - where have we succeeded and how
* Up and coming competitors to MabThera and strategies to maintain market lead
Dr. Bruno Osterwalder
VP, Global Head, Early & Strategic Oncology
Roche
10:20 CASE STUDY: Zevalin, A Novel Treatment Regime
Zevalin is the first product with a monoclonal antibody that is combined with a radioactive chemical for the treatment of non-Hodgkin lymphoma
* Two part administration of Zevalin: screening and treatment
* Results from Safety and Efficacy studies
* Toxicity of treatment - limiting use and how to overcome this
* How effective is it in patients who are refractory to antibody treatment?
Dr. Iris Kuss
COE Study Management Europe
Schering
11:00 Morning Coffee
NOVEL BIOLOGICS: ANTISENSE
11:20 How can You Get Antisense onto the Market
* Developing novel and specific classes of drugs - how to rapidly and effectively capitalize on information
* Recent advances in oligonucleotide technology - how will this impact the process of your drug discovery?
* Developing antisense oligonucleotides as therapeutic agents
* Antisense mechanisms - RNase H based and siRNA
* Status and progress of antisense in clinical studies in oncology
Dr. Nick Dean
Vice President Functional Genomics
Isis Pharmaceuticals
NOVEL BIOLOGICS: VACCINES
12:00 CASE STUDY: Oncophage, the Invesigational Personalised Melanoma Vaccine
* Capturing the antigenic footprint - how to use this to control cancer
* Advantages over conventional treatment - no more debilitating side effects
* Fast track status - what will this mean to the market
* Ongoing product development strategies: clinical trials to efficacy data
Dr. Renu Gupta
Senior Vice President, Development
Antigenics
12:40 Lunch
NOVEL BIOLOGICS: ANGIOGENESIS INHIBITORS
14:00 CASE STUDY: Commercialisation of Thalidomide
* Proposed mechanism of Thalidomide action
* S.T.E.P.S: a unique distribution system
* The role of the independent investigator in clinical trials
* Thalidomide as a treatment for haematological and oncological conditions - is it effective?
* Clinical development of the ImiDs and SelCIDs
Dr. Ken Watters
VP, Clinical Development and Regulatory Affairs
Celgene Europe Limited
14:40 Anti-Angiogenic Strategies: Targeting the VEGF Receptors KDR and flt1
* Proteins and small molecules as anti-angiogenic agents
* Ongoing preclinical research - how to get it right
* KDR antibody phase I studies and efficacy in a leukemia model
* Therapeutic potential of VEGFR1 (flt1)
* VEGF receptor antibodies in a model of atherosclerosis
* Current research goals: increasing efficacy and tolerability
Dr. Peter Bohlen
Senior VP, Research
ImClone Systems
15:20 Afternoon Tea
PHARMACEUTICAL ALLIANCES
15:40 CASE STUDY: HAP Technology for Pharmaceutical Research
* DNA-based diagnostics and therapeutic products
- integrating genetic variation and population genomics
- developing, marketing and prescribing
* HAP database and DecoGen Informatics System
* STRENGTH study: AstraZeneca licensing agreement
Krishnan Nandabalan
VP Business Development
Genaissance
16:20 Big Pharma and Biotech Alliances: Perlegen Sciences Case Study
* Perlegen-identified single nucleotides: DNA scanning technology
* Genome scanning project
* Benefits of scanning clinical trial participants
* Multiple collaborations
Paul Cusenza
Vice President, Alliance Management
Perlegen Sciences
17:00 Questions and Discussion
17:20 Chairman summation
17:30 Close of Conference
Terms & Conditions
NB - Due to high demand, we do not 'reserve' or 'hold' places - a request for an invoice to be raised will be treated as an official booking and will be subject to the cancellation policy as outlined below.
Cancellations/substitutions and name changes: All bookings carry a 50% liability after the booking has been made, by post fax, email or web. There will be no refunds for cancellations received on or after one month before the start of the conference (e.g. cancellation on or after 20th January for a conference starting on 20th February). If you decide to cancel after this date the full invoice remains payable. Conference notes, which are available on the day, will be sent to you. Unfortunately we are not able to transfer places between conferences and executive briefings. However if you are unable to attend the event you may make a substitution/name change at any time as long as we are informed in writing by e-mail, fax or post. Name changes and substitutions must be from the same company and are not transferable between companies or countries.
Indemnity: visiongain Ltd reserve the right to change the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled due to acts of terrorism, war, extreme weather conditions, industrial action, acts of God or any event beyond the control of visiongain Ltd. If such a situation arises we will endeavour to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or cancelled. We therefore strongly advise all customers to take out insurance to cover the cost of the registration, travel and expenses.
To unsubscribe please reply with unsubscribe in the subject line.
Data protection: Visiongain Ltd gathers and manages data in accordance with the Data Protection Act 1998. Information contained about you may be used to update you on visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. If you wish your details to be amended, please send your request to the Database Manager, visiongain Ltd, 40 Tooting High Street, London, SW17 0RG. Alternatively please reply with unsubscribe in the subject line. Please allow approximately 7 days for your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes come into effect.
WOSP is a forum for researchers interested in the intersection of Software Engineering and Performance Evaluation. Software Performance Engineering (SPE) research aims to build predictable performance into software by specifying and analysing quantitative behaviour from the early development phases
of a system throughout its entire life cycle. Analysis may be based on various kinds of modelling, design and measurement tools. Modern software systems are complex (distributed over a wide area, mobile, running on heterogeneous platforms, belonging to different administrative domains) and often
have strict performance and scalability requirements. This workshop brings together software engineers, developers, performance analysts and modellers who address the challenges of increasing system complexity, rapidly evolving software technologies, short time to market, incomplete documentation,
and less than adequate quantitative models and tools. We expect a strong mixture of academic and industrial participation.
The conference will be held in Palma, Spain on 11-15 July 2005.
Further information including the complete call for papers can be found at <http://wosp2005.uib.es/pre.htm> http://wosp2005.uib.es/pre.htm .
APOLOGIES FOR MULTIPLE COPIES
The submission deadline is this week: Friday September 10 (firm)
^^^^^^^^^^^^^^^^^^^
***************************************************
******** FINAL CALL FOR PAPERS ********
***************************************************
* *
* QoS-IP 2005 *
* The Third International Workshop on *
* QoS in Multiservice IP Networks *
* *
* Catania, Italy -- February 2-4, 2005 *
* *
* http://www.tlc-networks.polito.it/QoS-IP2005/ *
* *
***************************************************
Technical Co-Sponsorship by the IEEE ComSoc TCCC and TC-CSIM
Topics:
- Architectures for the provision of QoS guarantees
in IP networks
- End-to-end QoS in IP networks
- Adaptive and customizable QoS provision
- Network planning and optimization for QoS
- Traffic models for QoS network design
- Analytical and simulation models for QoS estimation
- Fluid models for QoS estimation in large IP networks
- Experimental results on QoS
- QoS in wireless/mobile IP networks
- QoS in photonic IP networks
- QoS for special environments (Peer-to-peer, infomobility,
broadcasting, ...)
- Mapping and Interworking between Local QoS and
end-to-end QoS mechanisms
Deadlines:
September 10th, 2004 Electronic Paper Submission
November 1st, 2004 Acceptance Notification
November 15th, 2004 Final Version Due
Information:
http://www.tlc-networks.polito.it/QoS-IP2005/
Keynote speakers
----------------
Francois Baccelli, Ecole Normale Superieure, Paris, France
Rene Cruz, University of California, San Diego, USA
Henning Schulzrinne, Columbia University, New York, USA
Organizing Committee
--------------------
General Chair
Marco Ajmone Marsan, Politecnico di Torino, Italy
Program Committee Co-chairs
Giuseppe Bianchi, University of Rome Tor Vergata, Italy
Marco Listanti, University of Rome La Sapienza, Italy
Michela Meo, Politecnico di Torino, Italy
Local Arrangements Chair
Giovanni Schembra, University of Catania, Italy
Finance Chair
Alfio Lombardo, University of Catania, Italy
Publications Chair
Raffaele Bolla, University of Genova, Italy
Information System Chair
Maurizio M. Munafo', Politecnico di Torino, Italy
[Apologies for multiple copies of this announcement]
CALL FOR PARTICIPATION
RAID 2004
"Intrusion Detection and Society"
Seventh International Symposium on
Recent Advances in Intrusion Detection
Sponsored by SAP, France Telecom, and Région PACA
Institut Eurecom, Sophia-Antipolis, French Riviera, France
September 15-17, 2004
http://raid04.eurecom.fr
RAID 2004 will be collocated with ESORICS 2004
The RAID symposium brings together leading researchers and practitioners from
academia, government, and industry to discuss intrusion detection technologies
and issues from research and commercial perspectives.
This year's program features a single technical track with 14 full papers and
2 practical experience reports selected from almost 120 submissions. It also
includes invited speakers, a poster session as well as an abstracts' session.
TECHNICAL PROGRAM
-----------------
Wednesday, September 15th
=========================
09.00 Registration opens
12.30 Lunch
14.00 - 14.15 Welcome
14.15 - 15.15 Invited Talk: Lessons in Intrusion Detection
Bruce Schneier, Counterpane Internet Security, CA, USA
15.15 - 15.45 Coffee break
15.45 - 16.45 Modelling process behaviour - Chair: Alfonso Valdes,
(SRI International, USA)
Automatic Extraction of Accurate Application-Specific
Sandboxing Policy,
Lap-chung Lam and Tzi-cker Chiueh,
Rether Networks Inc., Centereach N.Y., USA
Context Sensitive Anomaly Monitoring of Process Control
Flow to Detect Mimicry Attacks and Impossible Paths,
Haizhi Xu, Wenliang Du, and Steve J. Chapin,
Systems Assurance Institute, Syracuse University, USA
16.45 - 17.00 Break
17.00 - 18.00 Abstract session
18.00 - Poster session
Thursday, September 16th
========================
09.00 - 10.30 Detecting Worms and Viruses - Chair: John McHugh
(CMU/SEI CERT, USA)
HoneyStat: Local Worm Detection Using Honeypots,
David Dagon, Xinzhou Qin, Guofei Gu, Wenke Lee, Julian
Grizzard, John Levine, and Henry Owen,
Georgia Institute of Technology, USA
Fast Detection of Scanning Worm Infections,
Jaeyeon Jung (1), Stuart E. Schechter (2),
and Arthur W. Berger (1),
(1) MIT CSAIL, USA
(2) Harvard DEAS, USA.
Detecting Unknown Massive Mailing Viruses Using
Proactive Methods
Ruiqi Hu and Aloysius K. Mok,
Dept of Computer Sciences, University of Texas at Austin, USA
10.30 - 11.00 Coffee break
11.00 - 12.30 Attack and Alert Analysis - Chair: Diego Zamboni
(IBM Research, Switzerland)
Using Adaptive Alert Classification to Reduce False Positives
in Intrusion Detection,
Tadeusz Pietraszek,
IBM Zürich Research Laboratory, Switzerland.
Attack Analysis and Detection for Ad Hoc Routing Protocols
Yi-an Huang, Wenke Lee,
College of Computing, Georgia Institute of Technology, USA.
On the Design and Use of Internet Sinks for Network Abuse
Monitoring
Vinod Yegneswaran (1), Paul Barford (1), Dave Plonka (2),
(1) Dept of Computer Science, University of Wisconsin,
Madison, USA,
(2) Dept of Information Technology, University of Wisconsin,
Madison, USA
12.30 - 14.00 Lunch
14.00 - 15.00 Invited Talk: Fighting Fraud in Telecom Environments
Håkan Kvarnström
TeliaSonera AB, Sweden
15.00 - 15.30 Coffee break
15.30 - 16.30 Practical Experience - Chair: George Mohay
(Queensland University of Technology, Australia)
Monitoring IDS Background Noise Using EWMA Control
Charts and Alert Information
Jouni Viinikka and Herve Debar,
France Telecom R&D, Caen, France
Experience with a Commercial Deception System,
Brian Hernacki, Jeremy Bennett, Thomas Lofgren,
Symantec Corporation, Redwood City, USA
16.30 - 17.30 Poster session
Friday, September 17th
======================
09.00 - 10.30 Anomaly Detection - Chair: Christopher Kruegel,
(Technical University of Vienna, Austria)
Anomalous Payload-based Network Intrusion Detection
Ke Wang Salvatore J. Stolfo,
Computer Science Dept, Columbia University, USA
Anomaly Detection Using Layered Networks Based on Eigen
Co-occurrence Matrix
Mizuki Oka (1), Yoshihiro Oyama (2,3), Hirotake Abe (1), and
Kazuhiko Kato (1,3),
(1) University of Tsukuba, Japan,
(2) University of Tokyo, Japan,
(3) Japan Science and Technology Cooperation, Japan
Seurat: A Pointillist Approach to Anomaly Detection
Yinglian Xie (1), Hyang-Ah Kim (1), David R. O'Hallaron (1,2)
Michael K. Reiter (1,2), and Hui Zhang (1,2),
(1) Dept of Computer Science, Carnegie-Mellon University, USA
(2) Dept of Electrical and Computer Engineering,
Carnegie-Mellon University, USA
10.30 - 11.00 Coffee Break
11.00 - 12.30 Formal Analysis for Intrusion Detection - Chair: Wenke Lee
(Georgia Tech, USA)
Detection of Interactive Stepping Stones with Maximum
Delay Bound: Algorithms and Confidence Bounds
Avrim Blum, Dawn Song, Shobha Venkataraman
Carnegie Mellon University, USA.
Formal Reasoning about Intrusion Detection Systems
Tao Song (1), Calvin Ko (2), Jim Alves-Foss (3),
Cui Zhang (4), and Karl Levitt (1),
(1) Computer Security Laboratory, University of California,
Davis, USA,
(2) NAI LAbs, Network Associates Inc., Santa Clara, CA, USA,
(3) Center for Secure and Dependable Systems, University
of Idaho, USA
(4) Computer Science Dept, California State University,
Sacramento, USA.
RheoStat : Real-time Risk Management
Ashish Gehani and Gershon Kedem,
Dept of Computer Science, Duke University, USA
12.30 - 12.45 Concluding remarks
12.45 - 14.00 Lunch
ORGANIZING COMMITTEE
--------------------
General Chair: Refik Molva <refik.molva(a)eurecom.fr>
Program Chairs: Erland Jonsson <erland.jonsson(a)ce.chalmers.se>
Alfonso Valdes <valdes(a)sdl.sri.com>
Publication Chair: Magnus Almgren <almgren(a)ce.chalmers.se>
Publicity Chair: Yves Roudier <Yves.Roudier(a)eurecom.fr>
Sponsor Chair: Marc Dacier <marc.dacier(a)eurecom.fr>
PROGRAM COMMITTEE
-----------------
Tatsuya Baba (NTT Data, Japan)
Lee Badger (DARPA, USA)
Sungdeok Cha (KAIST, Korea)
Steven Cheung (SRI International, USA)
Herve Debar (France Telecom R&D, France)
Simone Fischer-Hubner (Karlstad University, Sweden)
Steven Furnell (University of Plymouth, UK)
Dogan Kesdogan (RWTH Aachen, Germany)
Chris Kruegel (Technical University of Vienna, Austria)
Hakan Kvarnstrom (TeliaSonera R&D, Sweden)
Wenke Lee (Georgia Tech, USA)
Douglas Maughan (DHS HSARPA, USA)
Roy Maxion (Carnegie Mellon University, USA)
John McHugh (CMU/SEI CERT, USA)
Ludovic Me (Supelec, France)
George Mohay (Queensland University of Technology, Australia)
Vern Paxson (ICSI and LBNL, USA)
Giovanni Vigna (UCSB, USA)
Andreas Wespi (IBM Research, Switzerland)
Felix Wu (UC Davis, USA)
Diego Zamboni (IBM Research, Switzerland)
STEERING COMMITTEE
------------------
Chair: Marc Dacier (Eurecom, France)
Herve Debar (France Telecom R&D, France)
Deborah Frincke (University of Idaho, USA)
Huang Ming-Yuh (The Boeing Company, USA)
Wenke Lee (Georgia Institute of Technology, USA)
Ludovic Me (Supelec, France)
S. Felix Wu (UC Davis, USA)
Andreas Wespi (IBM Research, Switzerland)
Giovanni Vigna (UCSB, USA)
VENUE / TRAVEL
--------------
RAID 2004 will be held on the French Riviera coast, about 20 km West of Nice
and 15 km Northeast of Cannes. The conference will take place at Institut
Eurecom / CICA, in the Sophia Antipolis science park, which can easily be
reached thanks to the nearby Nice international airport. For more
information, refer to: http://raid04.eurecom.fr/visitor_information.html
[Apologies for multiple copies of this announcement]
CALL FOR PARTICIPATION
ESORICS 2004
9th European Symposium on Research in Computer Security
Sponsored by SAP, @sec, and Région PACA
Institut Eurecom, Sophia Antipolis, French Riviera, France
September 13-15, 2004
http://esorics04.eurecom.fr
ESORICS 2004 will be collocated with RAID 2004
Since 1990, ESORICS has been confirmed as the European research event in
computer security, attracting audience from both the academic and industrial
communities. The symposium has established itself as one of the premiere,
international gatherings on Information Assurance. This year's three days
program will feature a single technical track with 27 full papers selected
from almost 170 submissions.
TECHNICAL PROGRAM
-----------------
Monday, September 13th
======================
09:15 - 09:30 opening remarks
09:30 - 10:30 invited talk: Enterprise Privacy Management
Michael Waidner - IBM Zurich Research Laboratory, Switzerland
10:30 - 11:00 coffee break
11:00 - 12:30 Access control
--------------
Incorporating Dynamic Constraints in the Flexible Authorization Framework
Shiping Chen, Duminda Wijesekera, Sushil Jajodia
Access-Condition-Table-driven Access Control for XML Database
Naizhen Qi, Michiharu Kudo
An Algebra for Composing Enterprise Privacy Policies
Michael Backes, Markus Duermuth, Rainer Steinwandt
12:30 - 14:00 lunch
14:00 - 15:30 Cryptographic protocols
-----------------------
Deriving, attacking and defending the GDOI protocol
Catherine Meadows, Dusko Pavlovic
Better Privacy for Trusted Computing Platforms
Jan Camenisch
A Cryptographically Sound Dolev-Yao Style Security Proof of the Otway-Rees
Protocol
Michael Backes
15:30 - 16:00 coffee break
16:00 - 17:30 Anonymity and information hiding
--------------------------------
A Formalization of Anonymity and Onion Routing
Sjouke Mauw, Jan Verschuren, Erik de Vink
Breaking Cauchy Model-based JPEG Steganography with First Order Statistics
Rainer Böhme, Andreas Westfeld
Comparison between two practical mix designs
Claudia Diaz, Len Sassaman, Evelyne Dewitte
Tuesday, September 14th
=======================
09:00 - 10:30 Distributed data protection
---------------------------
Signature Bouquets: Immutability for Aggregated/Condensed Signatures
Einar Mykletun, Maithili Narasimha, Gene Tsudik
Towards a theory of data entanglement
James Aspnes, Joan Feigenbaum, Aleksandr Yampolskiy, Sheng Zhong
Portable and Flexible Document Access Control Mechanisms
Mikhail Atallah, Marina Bykova
10:30 - 11:00 coffee break
11:00 - 12:30 Information flow and security properties
----------------------------------------
Possibilistic Information Flow Control in the Presence of Encrypted
Communication
Dieter Hutter, Axel Schairer
Information flow control revisited: Noninfluence = Noninterference +
Nonleakage
David von Oheimb
Security Property Based Administrative Controls
Jon A. Solworth, Robert H. Sloan
12:30 - 14:00 lunch
14:00 - 15:30 Authentication and trust management
-----------------------------------
A Vector Model of Trust for Developing Trustworthy Systems
Indrajit Ray, Sudip Chakraborty
Parameterized Authentication
Michael J. Covington, Mustaque Ahamad, Irfan Essa, H. Venkateswaran
Combinatorial Design of Key Distribution Mechanisms for Wireless Sensor
Networks
Bulent Yener, Seyit A. Camtepe
15:30 - 16:00 coffee break
16:00 - 17:30 Cryptography
------------
IPv6 Opportunistic Encryption
Claude Castelluccia, Gabriel Montenegro, Julien Laganier, Christoph Neumann
On the role of key schedules in attacks on iterated ciphers
Lars R. Knudsen, John E. Mathiassen
A Public-Key Encryption Scheme with Pseudo-Random Ciphertexts
Bodo Möller
Wednesday, September 15th
=========================
09:00 - 10:30 Operating systems and architecture
----------------------------------
A Host Intrusion Prevention System for Windows Operating Systems
Roberto Battistoni, Emanuele Gabrielli, Luigi Vincenzo Mancini
Re-establishing Trust in Compromised Systems: Recovering from Rootkits
that Trojan the System Call Table
Julian Grizzard, John Levine, Henry Owen
ARCHERR: Runtime Environment Driven Program Safety
Ramkumar Chinchani, Anusha Iyer, Bharat Jayaraman, Shambhu Upadhyaya
10:30 - 11:00 coffee break
11:00 - 12:30 Intrusion detection
-------------------
Sets, Bags, and Rock and Roll Analyzing Large Data Sets of Network Data
John McHugh
Redundancy and diversity in security
Bev Littlewood, Lorenzo Strigini
Discover Novel Attack Strategies from INFOSEC Alerts
Xinzhou Qin, Wenke Lee
ORGANIZING COMMITTEE
--------------------
General Chair
Refik Molva
Institut Eurecom
email: Refik.Molva(a)eurecom.fr
Program Chairs
Peter Ryan Pierangela Samarati
University of Newcastle upon Tyne University of Milan
email: Peter.Ryan(a)newcastle.ac.uk email: samarati(a)dti.unimi.it
Publication Chair Publicity Chair
Dieter Gollmann Yves Roudier
TU Hamburg-Harburg Institut Eurecom
email: diego(a)tuhh.de email: roudier(a)eurecom.fr
Sponsoring Chair
Marc Dacier
Institut Eurecom
email: dacier(a)eurecom.fr
PROGRAM COMMITTEE
-----------------
Vijay Atluri, Rutgers University, USA
Giampaolo Bella, Università di Catania, Italy
Joachim Biskup, Universitaet Dortmund, Germany
Jan Camenisch, IBM Research, Switzerland
Germano Caronni, Sun Microsystems Laboratories, USA
David Chadwick, University of Salford, UK
Ernesto Damiani, University of Milan, Italy
Sabrina De Capitani di Vimercati, University of Milan, Italy
Yves Deswarte, LAAS-CNRS, France
Alberto Escudero-Pascual, Royal Institute of Technology, Sweden
Csilla Farkas, University of South Carolina, USA
Simon Foley, University College Cork, Ireland
Dieter Gollmann, TU Hamburg-Harburg, Germany
Joshua D. Guttman, MITRE, USA
Sushil Jajodia, George Mason University, USA
Sokratis K. Katsikas, University of the Aegean, Greece
Maciej Koutny, University of Newcastle upon Tyne, UK
Peng Liu, Pennsylvania State University, USA
Javier Lopez, University of Malaga, Spain
Roy Maxion, Carnegie Mellon University, USA
Patrick McDaniel, AT&T Labs-Research, USA
John McHugh, CERT/CC, USA
Catherine A. Meadows, Naval Research Lab, USA
Refik Molva, Institut Eurécom, France
Peng Ning, NC State University, USA
LouAnna Notargiacomo, The MITRE Corporation, USA
Eiji Okamoto, University of Tsukuba, Japan
Stefano Paraboschi, University of Bergamo, Italy
Andreas Pfitzmann, TU Dresden, Germany
Bart Preneel, Katholieke Universiteit Leuven, Belgium
Jean-Jacques Quisquater, Microelectronic laboratory, Belgium
Steve Schneider, University of London, UK
Christoph Schuba, Sun Microsystems, Inc., USA
Michael Steiner, IBM T.J. Watson Research Laboratory, USA
Paul Syverson, Naval Research Laboratory, USA
Kymie M.C. Tan, Carnegie Mellon University, USA
Dan Thomsen, Tresys Technology, USA
Moti Yung, Columbia University, USA
VENUE / TRAVEL
--------------
ESORICS 2004 will be held on the French Riviera coast, about 20 km West of Nice
and 15 km Northeast of Cannes. The conference will take place at Institut
Eurecom / CICA, in the Sophia Antipolis science park, which can easily be
reached thanks to the nearby Nice international airport. For more
information, refer to: http://esorics04.eurecom.fr/visitor_information.html
CALL FOR PARTICIPATION
MMNS 2004: 7th International Conference on Management of Multimedia
Networks & Services
October 3-6, 2004, Hilton Hotel Harbor Island, San Diego, California,
USA, https://www.itsharenet.org/MMNS
KEYNOTES
"Ad-Hoc Multi-Hop Networking: Challenges and Experiences"
Pertti Alapuranen, Mesh Networks, Inc.
"Crossing the Multimedia Session Management Chasm"
Patrick Reilly, Intel Corporation
------------------------------------------------------------------------
---
PANEL SESSION:
"Knowledge Plane: Hype or Breakthrough in Managing Internet Networks"
David Clark, MIT CSAIL, USA
Simon Crosby, Intel Research, USA
Bob Briscoe, British Telecom, UK
John Strassner, MDAPCE, USA
------------------------------------------------------------------------
---
MAIN CONFERENCE PROGRAM TECHNICAL SESSIONS:
S1: Multimedia over Wireless
S2: Adaptive Multimedia Streaming
S3: Novel Protocols in Wireless Systems
S4: Scalable Multimedia Systems
S5: MPLS: Bandwidth Provisioning & Control
S6: Distributed Systems Management
S7: Proactive Quality of Service
S8: Multimedia Service Control and Management
S9: Mobility: Control and Management
------------------------------------------------------------------------
---
APPLICATION SESSION A:
"New Architectures in Next Generation Wireless/Multimedia Systems"
Raymond Liao, Siemens TTB Center, USA
Jesse Walker, Intel Corporation
Dirk Trossen, Nokia Research, USA
Dilip Krishnaswamy, Intel Corporation
APPLICATION SESSION B:
"Towards Implementing Network Autonomics"
John Strassner, MDAPCE, USA
David Durham, Intel Corporation
Kevin Twardus, IBM Corporation
------------------------------------------------------------------------
---
2ND WORKSHOP ON END-TO-END MONITORING TECHNIQUES AND SERVICES (E2EMON):
KEYNOTE SPEAKER - Keith Ross, Polytechnic University, USA
Workshop Sessions:
E1: Traffic Measurements and Analysis
E2: Path Monitoring
E3: Monitoring of Emerging Technologies
------------------------------------------------------------------------
---
TUTORIALS:
T1: IP Multimedia Subsystem (IMS): The Architecture of Choice for
Converging Networks
John G. Waclawsky, Cisco Systems, Inc.
T2: Cross-layer Optimization for Wireless Multimedia Transmission
Principles and Standards
Mihaela van der Schaar, UC Davis, USA
T3: Multimedia Traffic Modeling, Measurement and Control
George Pavlou, University of Surrey, UK
T4: IP-Oriented QoS in Wireless Networks
Pascal Lorenz, University of Haute Alsace, France
------------------------------------------------------------------------
---
Important Dates:
Early Registration Deadline: September 1, 2004
Hotel Registration Deadline: September 15, 2004
To register or for more information, visit
https://www.itsharenet.org/MMNS.
Organized by: IT@Intel Information Services and Technology Group
Research and School of Computer Science, Lancaster University, UK
Sponsored by: Intel Corporation, IFIP, IEEE, IEEE Communications Society